HomeComparePROCW vs GBDC

PROCW vs GBDC: Dividend Comparison 2026

PROCW yields 10309.28% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PROCW wins by $74444449017686384.00M in total portfolio value
10 years
PROCW
PROCW
● Live price
10309.28%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$74444449017686400.00M
Annual income
$73,050,544,679,942,830,000,000.00
Full PROCW calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — PROCW vs GBDC

📍 PROCW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPROCWGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PROCW + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PROCW pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PROCW
Annual income on $10K today (after 15% tax)
$876,288.66/yr
After 10yr DRIP, annual income (after tax)
$62,092,962,977,951,410,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, PROCW beats the other by $62,092,962,977,951,390,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PROCW + GBDC for your $10,000?

PROCW: 50%GBDC: 50%
100% GBDC50/50100% PROCW
Portfolio after 10yr
$37222224508843208.00M
Annual income
$36,525,272,339,971,425,000,000.00/yr
Blended yield
98.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

PROCW
No analyst data
Altman Z
0.9
Piotroski
6/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PROCW buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPROCWGBDC
Forward yield10309.28%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$74444449017686400.00M$20.78M
Annual income after 10y$73,050,544,679,942,830,000,000.00$16,389,263.41
Total dividends collected$74351742623648800.00M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: PROCW vs GBDC ($10,000, DRIP)

YearPROCW PortfolioPROCW Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$1,041,628$1,030,927.84$12,490$1,790.28+$1.03MPROCW
2$101,473,713$100,359,170.93$16,522$3,157.73+$101.46MPROCW
3$9,245,800,644$9,137,223,771.45$23,578$5,898.68+$9245.78MPROCW
4$787,968,000,080$778,074,993,390.97$37,115$11,886.75+$787967.96MPROCW
5$62,816,013,853,671$61,972,888,093,585.02$66,136$26,423.57+$62816013.79MPROCW
6$4,684,424,446,980,322$4,617,211,312,156,894.00$137,257$66,491.44+$4684424446.84MPROCW
7$326,809,221,096,547,600$321,796,886,938,278,660.00$341,734$194,868.54+$326809221096.21MPROCW
8$21,331,166,081,354,670,000$20,981,480,214,781,362,000.00$1,050,788$685,133.02+$21331166081353.62MPROCW
9$1,302,714,334,339,765,600,000$1,279,889,986,632,716,000,000.00$4,099,314$2,974,971.01+$1302714334339761.50MPROCW
10$74,444,449,017,686,390,000,000$73,050,544,679,942,830,000,000.00$20,775,530$16,389,263.41+$74444449017686384.00MPROCW

PROCW vs GBDC: Complete Analysis 2026

PROCWStock

Procaps Group, S.A. operates as an integrated healthcare and pharmaceutical company worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately ten therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg City, Luxembourg.

Full PROCW Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this PROCW vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PROCW vs SCHDPROCW vs JEPIPROCW vs OPROCW vs KOPROCW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.